1. Jones JS, Lane B, Mousa A, et al. Prostate cancers diagnosed at repeat biopsy are smaller and as likely to be high-grade. J Urol . 2008;180:1325-1329.

  2. Hodge KK, McNeal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol . 1989;142:66-70. 

  3. Hodge KK, McNeal JE, Terris MK, et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol . 1989;142:71-74; discussion 74-75.
  4. Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol . 1994;151:1571-1574. 

  5. Haas GP, Delongchamps NB, Jones RF, et al. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. J. Natl Cancer Inst . 2007;99:1484–1489.
  6. Hong YM, Lai FC, Chon CH, et al. Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies. Urol Oncol . 2004;22:7-10.

  7. Thompson IM, Ankerst DP, Chi C, et al. Assessing prostate cancer risk: results from the Prostate 
Cancer Prevention Trial. J Natl Cancer Inst . 2006;98:529-534. 

  8. Nguyen CT, Yu C, Moussa AS, et al. Performance of the Prostate Cancer Prevention Trial Risk calculator in a contemporary cohort of men screened for prostate cancer and diagnosed with extended prostate biopsy schemes. J Urol . 2010;183:529-533. 

  9. Hong YM, Lai FC, Chon CH, et al. Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies. Urol Oncol . 2004;22:7-10.

  10. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol . 1997;157:199-202.

  11. Presti JC, Jr., Chang JJ, Bhargava V, et al. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol . 2000; 163:163-166.

  12. Gore JL, Shariat SF, Miles BJ, et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol . 2001;165:1554-1559.
  13. Presti JC, Jr., O’Dowd GJ, Miller MC, et al. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol . 2003;169:125-129.

  14. Berger AP, Gozzi C, Steiner H, et al. Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. J Urol . 2004; 171:1478-1480.
  15. Jones JS, Patel A, Schoenfield L, et al. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol . 2006;175:485-488.

  16. Baccala Jr. AA, Moussa AS, Elbary AA, et al. Risk Factors and predictors of prostate cancer in men with negative repeat saturation biopsy. UroToday International Journal , Volume 3, February 2010.
  17. Lee MC, Moussa AS, Yu C, et al. Multifocal high-grade prostatic intraepithelial neoplasia is a risk factor for subsequent development of prostate cancer. J Urol . 2010;184:1958-1962.

  18. Abouassaly R, Tan N, Moussa A, Jones JS. Risk of Prostate Cancer After Diagnosis of Atypical Glands Suspicious for Carcinoma on Saturation and Traditional Biopsies. J Urol . 2008;180:911-914.
  19. Wolters T, van der Kwast TH, Vissers CJ, et al. GJ. False-negative prostate needle biopsies: frequency, histopathologic features, and follow-up. Am J Surg Pathol . 2010;34:35-43. 

  20. Catalona, WJ, Partin AW, Slawin KM, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA . 1998;279:1542-1547.

  21. Lee B, Jones JS. Percent Free PSA: Implications in modern extended scheme prostate biopsy. (Accepted for publication in Urology , June 2010).

  22. Lopez-Corona E, Ohori M, Scardino, PT, et al. A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. J Urol . 2003;170:1184-1188.
  23. Yanke BV, Gonen M, Scardino, PT, Kattan MW. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. J Urol . 2005;173:421-424.

  24. Walz J, Graefen M, Chun FK, et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol . 2006;50:498-505.

  25. Patel AR, Jones JS, Rabets J et al. Parasagittal biopsies add minimal information in repeat saturation prostate biopsy. Urology . 2004;63:87-99.

  26. Zaytoun O, Moussa A, Gao T, et al. Office-based transrectal saturation biopsy improves prostate 
cancer detection in the repeat biopsy population. 
Data in press.

  27. Lefkowitz GK, Sidhu GS, Torre P, et al. Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling? Urology . 2001;58:999-1003.

  28. McNeal JE, Redwine EA, Freiha FS, et al. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol . 1988;12:897-906.

  29. Bazinet M, Karakiewicz PI, Aprikian AG et al. Value of systematic transition zone biopsies in the early detection of prostate cancer. J Urol . 1996;155:605-606.

  30. Terris MK, Pham TQ, Issa MM, et al. Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J Urol . 1997;157:204-206.

  31. Epstein JI, Walsh PC, Sauvageot J, et al. Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer. J Urol . 1997;158:1886-1890.
  32. Takashima R, Egawa S, Kuwao S, et al. Anterior distribution of Stage T1c nonpalpable tumors in radical prostatectomy specimens. Urology . 2002;59:692-697.

  33. Bott SR, Young MP, Kellett MJ, et al. Anterior prostate cancer: is it more difficult to diagnose? BJU Int . 2002;89:886-889.

  34. Bouyé S, Potiron E, Puech P, et al. Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology. Prostate . 2009;69:105-113. 

  35. Wright JL, Ellis WJ. Improved prostate cancer detection with anterior apical prostate biopsies. Urol Oncol . 2006;24:492-495.

  36. Ching CB, Moussa AS, Li J, et al. Does transrectal ultrasound probe really matter? End fire versus side fire prostate cancer detection rates. J Urol . 2009;181;2077-2082. 

  37. Karakiewicz PI, Bazinet M, Aprikian AG et al. Outcome of sextant biopsy according to gland volume. Urology . 1997;49:55-59.

  38. Djavan B, Zlotta AR, Remzi M, et al. Total and transition zone prostate volume and age: how do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection? Urology . 1999;54:846-852.

  39. Borboroglu PG, Comer SW, Riffenburgh RH, et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol . 2000;163:158-162. 

  40. Stewart CS, Leibovich BC, Weaver AL, et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol . 2001;166:86-91. 

  41. Epstein JI, Sanderson H, Carter HB, Scharfstein DO. Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy. Urology . 2005;66:356-360.

  42. Bott SR, Henderson A, Halls JE, et al. Extensive transperineal template biopsies of prostate: modified technique and results. Urology . 2006;68:1037-1041.

  43. Satoh T, Matsumoto K, Fujita T, et al. Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. Urology . 2005;66:114-118.

  44. Moran BJ, Braccioforte MH, Conterato DJ. Re-biopsy of the prostate using a stereotactic transperineal technique. J Urol . 2006;176(4 Pt 1):1376-1381.

  45. Rabets JC, Jones JS, Patel A, Zippe CD. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. J Urol . 2004;172:94-97.

  46. Walz J, Graefen M, Chun FK, et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol . 2006;50:498-505. 

  47. de la Taille A, Antiphon P, Salomon L, et al. Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology . 2003;61:1181-1186. 

  48. Noworolski SM, Vigneron DB, Chen AP, Kurhanewicz J. Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magn Reson Imaging . 2008.26:1071-1080.

  49. Puech P, Betrouni N, Makni N, et al. Computer-assisted diagnosis of prostate cancer using DCE-MRI data: design, implementation and preliminary results. Int J Comput Assist Radiol Surg . 2009;4:1-10.

  50. Bozeman CB, Carver BS, Eastham JA. Treatment of chronic prostatitis lowers serum prostate specific antigen. J Urol . 2002;167:1723-1726.

  51. Karazanashvili G, Managadze L. Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination. Eur Urol . 2001;39:538-543.

  52. Lorente JA, Arrango O, Bielsa O, et al. Effect of antibiotic treatment on serum PSA and percent free PSA levels in patients with biochemical criteria for prostate biopsy and previous lower urinary tract infections. Int J Biol Markers . 2002;17:84-89.

  53. Bulbul MA, Wazzan W, Hijaz A, Shaar A. The effect of antibiotics on elevated serum prostate specific antigen in patients with urinary symptoms and negative digital rectal examinationa pilot study. J Med Liban . 2002;50:23-25. 

  54. De Sio M, D’Armiento M, Di Lorenzo G, et al. The need to reduce patient discomfort during transrectal ultrasonography-guided prostate biopsy: what do we know? BJU Int . 2005;96:977-983.

  55. Andriole GL, Bostwick DG, Brawley OW, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med . 2010;362:1192-1202.

  56. Roehrborn CG, Andriole GL, Wilson TH, et al. Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial. Eur Urol . 2010 (Epub ahead of print).

  57. Pannek J, Marks LS, Pearson JD, et al. Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasia. J Urol . 1998;159:449-453.

HOW TO TAKE THE POST-TEST: To obtain CME credit, please click here after reading the article to take the post-test on